Directory
>
Oliver Liesenfeld
Oliver Liesenfeld
Advisor | Inflammatix, Inc.
San Francisco, California, United States
Oliver Liesenfeld
Summary
Oliver Liesenfeld is an accomplished Chief Medical Officer with extensive experience in the biotechnology sector, particularly in clinical development and personalized medicine. He has successfully led large medical departments across various organizations, demonstrating a strong ability to navigate both corporate and startup environments. With over 175 publications to his name, his expertise spans multiple areas including cancer, infectious diseases, and immunology. Oliver holds an M.D. from Freie Universität Berlin, which complements his rich academic background, including roles as an associate professor. His work at Inflammatix focuses on innovative diagnostic solutions that leverage machine learning to improve patient outcomes. Oliver's passion for advancing medical science is evident in his commitment to research and clinical excellence, making him a respected leader in the field.
Oliver Liesenfeld
Work Experience
Advisor at
Inflammatix, Inc.
July 2024 - Present
Chief Medical Officer, Head of Clinical Affairs at
Inflammatix, Inc.
December 2017 - August 2024
VP, Chief Medical Officer, Head of Medical and Scientific Affairs at
ROCHE LEON HOLDINGS
June 2012 - October 2017
Sr. Director, Clinical Research and Scientific Affairs Microbiology at
ROCHE LEON HOLDINGS
July 2011 - June 2012
Director, Clinical Research and Scientific Affairs, Microbiology at
ROCHE LEON HOLDINGS
September 2008 - June 2011
Associate Professor of Medical Microbiology and Immunology of Infection at
Charite - Universitätsmedizin Berlin
June 2001 - September 2008
Assistant Professor for Medical Microbiology and Infection Immunology at
Charite Medical School Berlin
September 1998 - May 2001
Postdoctoral Fellow at
Leland Stanford Junior University
August 1994 - September 1998
Oliver Liesenfeld
Education
Freie Universität Berlin, M.D.
January 1983 - January 1988
University of Düsseldorf
January 1981 - January 1983
Krankenhaus Benrath
January 1980 - January 1981
Humboldt Gymnasium, Düsseldorf, Abitur (German High School Diploma)
January 1972 - January 1980
Frequently Asked Questions about Oliver Liesenfeld
What is Oliver Liesenfeld email address?
Oliver Liesenfeld's primary email address is ***********@inflammatix.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Oliver Liesenfeld work for?
Oliver Liesenfeld is a Advisor at Inflammatix, Inc., a company specializing in Commercial physical research.
Where Oliver Liesenfeld graduated from?
Oliver Liesenfeld holds a degree in Medicine from Freie Universität Berlin.
How can I directly contact Oliver Liesenfeld?
To contact Oliver Liesenfeld directly, you can use the email address ***********@inflammatix.com. Complete contact information is available upon registration with Muraena.
Is Oliver Liesenfeld an immigrant?
Yes, Oliver Liesenfeld is an immigrant and currently based in United States
Who is Oliver Liesenfeld?
Oliver Liesenfeld is an accomplished Chief Medical Officer with extensive experience in the biotechnology sector, particularly in clinical development and personalized medicine. He has successfully led large medical departments across various organizations, demonstrating a strong ability to navigate both corporate and startup environments. With over 175 publications to his name, his expertise spans multiple areas including cancer, infectious diseases, and immunology. Oliver holds an M.D. from Freie Universität Berlin, which complements his rich academic background, including roles as an associate professor. His work at Inflammatix focuses on innovative diagnostic solutions that leverage machine learning to improve patient outcomes. Oliver's passion for advancing medical science is evident in his commitment to research and clinical excellence, making him a respected leader in the field.
Oliver`s contact details
***********@inflammatix.com
Colleagues
Vice President Of Engineering
VP Machine Learning
VP, Quality Assurance and Regulatory Affairs at Inflammatix
Co-Founder And Chief Executive Officer, Inflammatix
Board Member
VP Strategy & Corporate Development
VP, Operations & Finance
Chief Technology Officer